Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Priya Life Science Sponsor trial record
Sponsor · clinical trials

University Children's Hospital Basel clinical trials

Source: ClinicalTrials.gov, U.S. National Library of Medicine — current trials in our Switzerland and France registers with University Children's Hospital Basel as lead sponsor. Synced 13 Nov 2026
7Current trials
7Recruiting now
0Drugs in these trials
2Trial registers
At a glance

University Children's Hospital Basel is the lead sponsor of 7 current clinical trials in our Switzerland and France registers. 7 are recruiting patients now. The most common phase is Observational. The most-studied condition is Thyroid Diseases.

ClinicalTrials.gov trials by status

  • Recruiting7100%

Trials by phase

  • Observational571%
  • Not applicable229%
01

Clinical trials sponsored by University Children's Hospital Basel

7 on ClinicalTrials.gov
StudyPhaseStatusStartRegisters
A Swiss Assessment of Hypothalamic-pituitary-adrenal Axis Suppression After Glucocorticoid Therapy for Leukemia and Lymphoblastic Lymphoma in Children
NCT06861530 · ClinicalTrials.gov ↗ · Adrenal Insufficiency, Leukemia, Lymphoblastic, Acute, Pediatric, Lymphoma, Lymphoblastic
Observational Recruiting 2024-08 Switzerland
Electrical Impedance Tomography for Identification of Optimal Positive End-expiratory Pressure in Newborn Infants
NCT05612256 · ClinicalTrials.gov ↗ · Positive End-expiratory Pressure (PEEP)
Observational Recruiting 2022-12 Switzerland
Restricted Versus Liberal Fluid Intake for Prevention of Bronchopulmonary Dysplasia
NCT06954142 · ClinicalTrials.gov ↗ · Bronchopulmonary Dysplasia
Not applicable Recruiting 2025-07 Switzerland
Exhaled Breath Analysis by Secondary Electrospray Ionization - Mass Spectrometry in Children and Adolescents
NCT04461821 · ClinicalTrials.gov ↗ · Respiratory Diseases, Neurological Disorders, Type 1 Diabetes
Observational Recruiting 2020-09 Switzerland
Prospective Evaluation of OptiThyDose
NCT06864351 · ClinicalTrials.gov ↗ · Thyroid Diseases, Congenital Hypothyroidism, Graves Disease
Not applicable Recruiting 2025-08 France, Switzerland
Early Pulmonary Dysfunction in Childhood Cancer Patients
NCT05427136 · ClinicalTrials.gov ↗ · Pulmonary Dysfunction
Observational Recruiting 2021-06 Switzerland
Diagnosis of Tuberculosis in Swiss Children
NCT03044509 · ClinicalTrials.gov ↗ · Tuberculosis, Mycobacterium Tuberculosis
Observational Recruiting 2017-05 Switzerland

Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.

02

Conditions in University Children's Hospital Basel trials

14 conditions
Thyroid Diseases1Congenital Hypothyroidism1Graves Disease1Adrenal Insufficiency1Leukemia, Lymphoblastic, Acute, Pediatric1Lymphoma, Lymphoblastic1Positive End-expiratory Pressure (PEEP)1Bronchopulmonary Dysplasia1Respiratory Diseases1Neurological Disorders1Type 1 Diabetes1Pulmonary Dysfunction1Tuberculosis1Mycobacterium Tuberculosis1
03

By trial register

RegisterTrialsRecruiting
Clinical trials in Switzerland77
Clinical trials in France11

A trial with sites in more than one country appears in each of those registers.

04

Other sponsors in Thyroid Diseases

SponsorTrials
Shanghai 6th People's Hospital4

Sponsors with the most current trials registered for this condition.

05

Questions about University Children's Hospital Basel trials

How many clinical trials does University Children's Hospital Basel sponsor?

University Children's Hospital Basel is the lead sponsor of 7 current trials on ClinicalTrials.gov in our Switzerland and France registers, as of the registry sync on 13 November 2026. Completed and withdrawn studies are not counted.

Are University Children's Hospital Basel trials recruiting?

Yes. 7 of its 7 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.

Where does this information come from?

Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.

Approvals, shortages and trials, every Friday

One email a week with new EMA and FDA approvals, EU and US medicine shortages, how many trials are recruiting in Ireland, and the week's Irish pharma news.

Free. Unsubscribe from any email with one click. See our privacy policy.

How this page is built

Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.

This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 13 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.

Please verify before you rely on this. This page is general information for life-science and pharmaceutical professionals. It is not medical advice, and it has not been reviewed by a clinician — our editorial team holds life-science qualifications, not clinical ones. It is not exhaustive and may not reflect the most recent label change. Always check the official prescribing information (US Prescribing Information or EU SmPC) and speak to your doctor or pharmacist before acting on anything here. Drugs in the same class are not automatically interchangeable, and approvals, brand names and indications differ between the US, the EU/Ireland (EMA/HPRA) and other regions. Spotted an error? Tell us — we correct promptly and log it.